Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBone Marrow TransplantationBlood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseBusulfanMyeloablative AgonistsBone MarrowHematopoietic Stem CellsTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCarmustineCytophagocytosisBone Marrow CellsIfosfamideHematopoiesisSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHodgkin DiseaseTransplantation ChimeraDisease-Free SurvivalCord Blood Stem Cell TransplantationTissue DonorsRetrospective StudiesNeoplasmsWhole-Body IrradiationSurvival RateTime FactorsSurvival AnalysisInfectionLymphoma, T-CellHistocompatibilityDoxorubicinPlatelet CountPOEMS SyndromeBone Marrow PurgingHistocompatibility TestingLeukemia, Myeloid, AcutePrednisoneImmunosuppressive AgentsCarboplatinTransplantation, IsogeneicLeukemiaBlood Cell CountDexamethasoneVidarabineRecombinant ProteinsFollow-Up StudiesBlood CellsAntineoplastic AgentsLymphomaBone Marrow DiseasesCytomegalovirus InfectionsProspective StudiesFatal OutcomeGraft vs Leukemia EffectBone and BonesAnemia, AplasticFeasibility StudiesMyelodysplastic SyndromesImmunophenotypingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionT-LymphocytesBlood Transfusion, AutologousLiver TransplantationHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocytes, MononuclearFlow CytometryCell SeparationHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsPrognosisHLA AntigensCyclosporineMesenchymal Stem Cell Transplantation